Abstract
Immunogenetics is the study of genetic factors that underlie variability in immune response in a broad sense, and may include graft rejection, immunoglobulin, blood group and histocompatibility antigen variation, and disease susceptibility. Although the immunogenetics of pregnancy is not well understood, significant variability exists with respect to maternal immune responses in pregnancy. For example, lymphocytotoxic alloantibodies and serum suppressor factors are present in the sera of some, but not all, multigravidas.1,2 The lack of certain immunologic responses in pregnancy, such as production of lymphocytotoxic alloantibodies or serum suppressor factors, is sometimes associated with fetal wastage.3
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amos DB. HL-A, fertility, and natural selection. Karolinska sumposia on research methods in reproductive endocrinology, 7th. Stockholm: Karolinska Institute. 1974:318–327.
Sargent LL, Wilkins T, Redman CWG. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet. 1988;2:1099–1104.
Beer AE, Semprini AE, Xiaoyu Z, Quebbeman JF. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles, female serum MLR blocking factors, and paternal leukocyte immunization. Exp Clin Immunogenet. 1985;2:137–153.
Weitkamp LW, Ober C, Schacter BZ. Genetic and immunogenetic markers of reproductive success. In: Clark DA, Croy BA, eds. Reproductive immunology 1986. Amsterdam: Elsevier; 1986:27–39.
Bulmer JN, Johnson PM. Antigen expression by trophoblast populations in the human placenta and their possible immunobiological relevance. Placenta. 1985;6:127–140.
Johnson PM, Risk JM, Bulmer JN, Niewola A, Kimber I. Antigen expression at human materno-fetal interface. In:Gill TJ, Wegmann TG, eds. Immunoregulation and fetal survival. New York: Oxford University Press; 1986:181–186.
Sunderland CA, Naiem M, Mason DY, Redman CWG, Stirrat GM. The expresssion of major histocompatibility antigens by human chorionic villi. J Reprod Immunol. 1981;3:323–331.
Ellis SA, Sargent IL, Redman CWG, Mc-Michael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. J Immunol. 1986; 59:595–601.
Kоvats S, Main EK, DeMars R. A non-classical class I antigen, HLA-G, is expressed in human first trimester trophoblasts. Proc Am Soc Histocompat Testing. 1989:104.
Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA. 1987;84:9145–9149.
Orr HT. HLA class I gene family: Characterization of genes encoding non-HLA-A,B,C proteins. In: Dupont B, ed. Immunobiology of HLA, vol. I: Histocompatibility testing 1987. New York: Springer-Verlag; 1987:33–39.
Levi-Straus M, Carroll MC, Steinmetz M, Meo T. A previously undetected MHC gene with an unusual periodic structure. Science. 1988; 240:201–204.
Carroll MC, Katzman P, Alicot P, et al. Linkage map of the human histocompatibility complex including the tumor necrosis factor. Proc Natl Acad Sci USA. 1987;84:8535–8539.
Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. HLA-E: A novel HLA class I gene expressed in resting T lymphocytes. J Immunol. 1988;141:897–903.
Fauchet R, Boscher M, Bouhallier O, et al. New class I in man: Serological and molecular characterization. Hum Immunol. 1986;17:3–20.
Trowsdale J, Young JAT, Kelly AP, et al. Structure, sequence, and polymorphism in the HLA-D region. Immunol Rev. 1985;85:5–43.
Bodmer WF, Albert E, Bodmer JG, et al. Nomenclature for factors of the HLA system, 1987. In: Dupont B, ed. Immunobiology of HLA, vol I: Histocompatibility testing 1987. New York: Springer-Verlag; 1987:72–79.
Yang SY. Nomenclature for HLA-A and HLA-B alleles detected by one-dimensional isoelectric focusing (1D-IEF) gel electrophoresis. In: Dupont B, ed. Immunobiology of HLA, vol I: Histocompatibility testing 1987. New York: Springer-Verlag; 1987:54–55.
Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1982;7:320–338.
Faulk WP, Hsi BL, Mclntyre JA, Yeh CJG, Mucchielli A. Antigens of the human extraembryonic membranes. J Reprod Fertil. 1982; 31(suppl): 181–189.
Johnson PM, Stern PL. Antigen expression at human materno-fetal interfaces. Prog Immunol. 1986;6:1056–1069.
Beer AE, Billingham RE. The immunobiology of reproduction. Englewood Cliffs, NJ: Prentice-Hall; 1976.
Beer AE, Quebbeman JF, Ayers JWT, Haines RF. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in human. Am J Obstet Gynecol. 1981;141:987–997.
Gleicher N, Siegel I. Pregnancy and the immune state. In: Davis T, ed. Autoimmune endocrine disease. New York: John Wiley; 1983:225.
Scott JR, Rote NS, Branch DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol. 1987;70:645–656.
Cowchock S, Dehoratius RD, Wapner RJ, Jackson LG. Subclinical autoimmune disease and unexplained abortion. Am J Obstet Gynecol. 1984;150:367–371.
Tiwari JL, Terasaki PI. HLA and disease association. New York: Springer-Verlag; 1985.
Onody C, Buc M, Gerencer M, et al. Association between T lymphocyte reactivity and HLA. Joint report from HLA-DR Intertransplant Workshop 1979. Tissue Antigens. 1980;16:10–13.
Gerencer M, Singer Z, Pfeifer S, et al. HLA and red blood group antigens in pregnancy disorders. Tissue Antigens. 1988;32:130–138.
Gerencer M, Kastelan A. The role of HLA-D region in feto-maternal interactions. Transplant Proc. 1983;15:893–895.
Reznikoff-Etievant MF, Edelman P, Muller JY, Pinon F, Sureau C. HLA-DR locus and maternal-foetal relation. Tissue Antigens. 1984;24: 30–34.
Jeannet M, Bischof P, Bourrit B, Vuagnat P. Sharing of HLA antigens in fertile, subfertile, and infertile couples. Transplant Proc. 1985;17:903–904.
Bolis PF, Bianchi MM, Soro V, Belvedere M. HLA typing in couples with repetitive abortion. Biol Res Preg. 1984;5:135–137.
Cauchi MN, Tait B, Wilshire MI, et al. Histocompatibility and habitual abortion. Am J Re-prod Immunol Microbiol. 1988;18:28–31.
Johnson PM, Chia KV, Risk JM, Barnes RMR, Woodrow JC. Immunological and immuno-genetic investigation of recurrent spontaneous abortion. Dis Markers. 1988;6:163–171.
Oksenberg JR, Persitz E, Amar A, Brautbar C. Maternal-paternal histocompatibility: Lack of association with habitual abortions. Fertil Steril. 1984;42:389–395.
Schacter B, Muir A, Gyves M, Tasin M. HLA-A,B compatibility in parents of offspring with neural-tube defects or couples experiencing involuntary fetal wastage. Lancet. 1979; 1:796–799.
Thomas ML, Harger JH, Wagener DK, Rabin BS, Gill TJ III. HLA sharing and spontaneous abortion in humans. Am J Obstet Gynecol. 1985;151:1053–1058.
Coulam CB, Moore SB, O’Fallon WM. Association between major histocompatibility antigen and reproductive performance. Am J Re-prod Immunol Microbiol. 1987;14:54–58.
Radcliffe JJ, Hart CA, Francis WJA, Johnson PM. Immunity to cytomegalovirus in women with unexplained recurrent spontaneous abortion. Am J Reprod Immunol Microbiol. 1986;12:103–105.
Johnson PM, Barnes RMR, Hart CA, Francis WJA. Determinants of immunological unresponsiveness in recurrent spontaneous abortion. Transplantation. 1984;38:280–284.
Komlos L, Zamir R, Joshua H, Halbrecht I. Common HLA antigens in couples with repeated abortions. Clin Immunol Immuno-pathol. 1977;7:330–335.
Gill TJ. Immunogenetics of spontaneous abortions in humans. Transplantation. 1983;35:1–6.
Risk JM, Johnson PM. Genetic studies of the MHC region in human recurrent spontaneous abortion. In: Gill TJ, Wegmann TG, eds. Molecular and cellular nature of maternal-fetal signalling. New York: Oxford University Press; 1989.
Mclntyre JA, Faulk P, Nichols-Johnson VR, Taylor CG. Immunologic testing and immunotherapy in recurrent spontaneous abortion. Obstet Gynecol. 1986;67:169–174.
Schacter B, Weitkamp LR, Johnson WE. Parental HLA compatibility in parents of offspring with neural-tube defects: Evidence for a T/t-like locus in humans. Am J Hum Genet. 1984;36:1082–1091.
Steinberg AG, Bleibtreu HK, Kurczynski TW, Martin AO, Kurczynski EM. Genetic studies in an inbred human isolate. In: Crow JF, Neel JV, eds. Proceedings of the third international congress of human genetics. Baltimore: Johns Hopkins University Press; 1967:267–290.
Martin AO. The founder effect in a human isolate: Evolutionary implications. Am J Phys Anthropol. 1970;32:351–368.
Ober C, Martin AO, Simpson JL, et al. Shared HLA antigens and reproductive performance in the Hutterites. Am J Hum Gen et. 1983,35:994–1004.
Ober C, Elias S, O’Brien E, Kostyu D, Hauck WW, Bombard A. HLA sharing and fertility in Hutterite couples: Evidence for prenatal selection against compatible fetuses. Am J Reprod Immunol Microbiol. 1988;18:111–115.
Hauck WW, Ober C. Statistical analysis of outcomes from repeated pregnancies: Effects of HLA sharing on fetal loss. Genet Epid. 1991;8:187–197.
Ober C, Elias S, Kostyu DD, Hauck WW. Decreased fecundability in Hutterite couples sharing HLA-DR. Am J Hum Gen. 1992;50:6–14.
Jazwinska EC, Kilpatrick DC, Smart GE, Liston WA. Feto-maternal HLA compatibility does not have a major influence on human pregnancy except for lymphocytotoxin production. Clin Exp Immunol. 1987;69:116–122.
Degos L, Colombani J, Chavantr A, Bengston B, Jaquard A. A selective pressure on HLA polymorphism. Nature. 1974;249:62–63.
Black FL. Motherchild HLA compatibility ratios in children of Amerindian parents who share common haplotypes. Am J Hum Genet. 1985;37:133–137.
Billington WD. Influence of immunologic dissimilarity of mother and foetus on size of placenta in mice. Nature. 1964;202:317–318.
James DA. Effects of antigenic dissimilarity of mother and foetus on size of placenta in mice. Nature. 1965;205:613–614.
Ober C, Simpson JL, Ward M, et al. Prenatal effects of maternal-fetal HLA compatibility. Am J Reprod Immunol Microbiol. 1987; 15:141–149.
Mills JL, Fishl AR, Knopp RL, Ober C, Jovanovich LG, Polk BF. Malformations in infants of diabetic mothers: Problems in study designs. Prev Med. 1983;12:274–286.
Beer AE. Pregnancy outcome in couples with recurrent abortions following immunological evaluation and therapy. In: Beard RW, Sharp F, eds. Early pregnancy loss: Mechanisms and treatment. New York: Springer-Verlag; 1988: 337–350.
Mowbry JF. Immunology of early pregnancy. Hum Reprod. 1988;3:79–82.
Takakuwa K, Goto Hasegawa I, Is immunotherapy for habitual aborters an immunologically hazardous procedure for infants? Am J Reprod Immunol. 1989;19:53–56.
Kirby DRS, McWhirter KG, Teitelbaum MS, Darlington DC. A possible immunological influence on the sex ratio. Lancet. 1967;1:139–140.
Ober C, Simpson JL, Radvany R. Increased male-to-female sex ratio among HLA-DR compatible pregnancies. Lancet. 1985;1:761.
Radvany RM, Vaisrub N, Ober C, Patel KM, Hecht F. The human sex ratio: Increase in firstborn males to parents with shared HLA-DR antigens. Tissue Antigens. 1987;29:34–42.
Kilpatrick DC. Feto-maternal HLA-DR compatibility and sex ratio. Tissue Antigens. 1987; 30:235–237.
Clayton J, Cambon-Thomsen A, Sevin A, Thomsen M, Ohayon E. No evidence of sex ratio distortion in relation with feto-maternal HLA-DR compatibility. Tissue Antigens. 1988; 32:286–290.
Ober C. The МНC complex in normal pregancy and spontaneous abortion. In: Gleicher N, Elkyam U, Galbraith RM, Gall SA, Sarto G, Sibai BM, eds. Principles of medical therapy in pregnancy. 2nd ed. New York: Appleton & Lange; 1990.
Caudle MR, Rote NS, Scott JR, DeWitt C, Barney MD. Histocompatibility in couples with recurrent spontaneous abortion and normal fertility. Fertil Steril. 1983;39:793–798.
Oksenberg JR, Persitz E, Amar A, et al. Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Fertil Steril. 1983;39:525–529.
Unander AM, Olding LB. Habitual abortion: Parental sharing of HLA antigens, absence of maternal blocking antibody, and suppression of maternal lymphocytes. Am J Reprod Immunol. 1983;4:171–178.
Vanoli M, Fabio G, Bonara P, et al. Histocompatibility in Italian couples with recurrent spontaneous abortions of unknown origin and with normal fertility. Tissue Antigens. 1985;26:227–233.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Ober, C. (1993). Immunogenetics of Fetal Growth and Development. In: Lin, CC., Verp, M.S., Sabbagha, R.E. (eds) The High-Risk Fetus. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9240-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9240-8_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9242-2
Online ISBN: 978-1-4613-9240-8
eBook Packages: Springer Book Archive